Adults 18 to 50, any sex, with Remote Ischemic Conditioning. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Dynamic Cerebral Autoregulation Parameter: Phase Difference(PD) in DegreePrimary· 36 days
Dynamic cerebral autoregulation (dCA) is an important indicator of cerebrovascular function which related to the prognosis of cerebrovascular disease. DCA is usually calculated by transfer function analysis. Phase Difference (PD) is gengreated. Low PD at a low frequency band indicates impairment of autoregulation, as it suggests that cerebral blood flow velocity follows the changes in arterial blood pressure with a short delay.
Group
Value
95% CI
RIC Group
45.87
± 13.02
Dynamic Cerebral Autoregulation Parameter: Gain in cm/s/mmHgSecondary· 36 days
High gain at the same frequency band is also considered an indicator of compromised autoregulation for passively transferring the amplitude of arterial blood pressure to cerebral blood flow velocity.
Group
Value
95% CI
RIC Group
0.95
± 0.25
Sponsor's own description
The purpose of this study is to determine the impact of serial remote ischemic conditioning on dynamic cerebral autoregulation and related hematology indexes in healthy adults.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
Other recruiting trials for Remote Ischemic Conditioning
Currently open trials in the same condition.
NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy
· NA
· recruiting
NCT06141525 — Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
· NA
· recruiting
Other The First Hospital of Jilin University trials
Trials by the same sponsor.
NCT07308340 — Rapid Identification of Infectious Pathogens in Severe Pneumonia Guided by Bronchoscopic Imaging and Lung CT
· not yet recruiting
NCT07369531 — The Impact of Two-Stage Turnbull-Cutait Pull-Through Coloanal Anastomosis on Stoma-free Survival in Low Rectal Anal-pres
· NA
· recruiting
NCT07414160 — Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients
· not yet recruiting
NCT07440368 — Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness
· not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit
· Phase 2, PHASE3
· recruiting
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The First Hospital of Jilin University
Last refreshed: 3 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04899362.